Home › Products › Gynaecology › Ovufol HP 75IU Injection
Ovufol HP 75IU Injection
Salt Composition: UROFOLLITROPIN
- Manufacturer: VHB LIFE SCIENCES INC
- Pack Size: 1 VIAL(s)
- Dosage Form: INJECTION
- Strength: 75IU
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Store Ovufol HP 75IU Injection between (2°C to 8°C) Do not freeze.
₹820.00₹1365.00
Inclusive of all taxes
Product Introduction
Ovufol HP 75IU Injection contains the active substance Urofollitropin. It is an ovulation stimulator that belongs to the group of medications called gonadotropins. It is used to treat infertility in women who are not ovulating, including those with polycystic ovarian disease, and who have not responded to treatment with another medicine called clomiphene citrate. It is also used to help multiple follicles develop and, therefore, to promote fertility in women undergoing IVF (in-vitro fertilisation) or other types of assisted conception. It is also indicated to treat infertility in men due to low sperm count.
Do not take Ovufol HP 75IU Injection if you are allergic to Urofollitropin or any of the other ingredients of this medicine. Do not take this medicine if you have a tumour in the pituitary gland (a gland located at the base of the brain which produces certain hormones, including growth hormones) or in the hypothalamus (an area located beneath the thalamus which controls conditions within your body including body temperature and blood pressure) or in the uterus, ovaries, breast, testicles, or in the prostate gland.
Before initiating treatment, you will be checked for underactive thyroid problems, hormone levels, and tumours of the pituitary and hypothalamus. Do not take Ovufol HP 75IU Injection if you have ovarian cysts that are not due to PCOD, vaginal bleeding, early menopause, physical problems in the reproductive organs, if your womb has been removed, or if you are pregnant or breastfeeding.
Inform your physician immediately if you experience any of the following symptoms: abdominal pain and swelling, weight gain, diarrhoea, difficulty in breathing, and decreased urination. Inform your physician if you have liver problems or a history of blood clotting disease before starting treatment with Ovufol HP 75IU Injection.
Uses
Ovufol HP 75IU Injection is used in the treatment of the following: Infertility in women
How it works
In the absence of sufficient endogenous luteinising hormone (LH), Ovufol HP 75IU Injection binds to the follicle-stimulating hormone receptor (FSH), resulting in ovulation. It also attaches to the LH receptor, causing appropriate hormone release and treating infertility in women.
How to Use
Ovufol HP 75IU Injection will be given to you by a doctor or nurse in a hospital or clinic setting. It is given as an intramuscular injection (into your muscles) or under the skin. Do not self-administer the injection. Your doctor will decide the dose, route of administration and duration of the treatment based on your disease severity, body weight, and other factors.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them. Serious side effects of Ovufol HP 75IU Injection are: Severe allergic reactions (hypersensitivity reactions) Common side effects of Ovufol HP 75IU Injection are: Abdominal pain or swelling Headache Nausea Pelvic pain Overstimulation of ovaries Pain or inflammation at the injection site Mood swings
Expert Tips
If you have missed any dosing appointments, inform your doctor and schedule immediately. Ovufol HP 75IU Injection can increase your risk of ectopic pregnancy (pregnancy outside of the womb) if you have a history of fallopian tube disease, miscarriage, multiple pregnancies (twins and triplets), and birth defects in the baby. Your doctor will regularly perform ultrasound scans and blood tests to monitor your response to the treatment.
References
- Merck Serono Ltd, Electronic medicines compendium (EMC), [Revised on Nov 2022] [ Accessed on 29th June 2023], https://www.medicines.org.uk/emc/files/pil.69.pdf
- Ferring Pharmaceuticals, US Food and Drug Administration, [Revised on Feb 2014] [ Accessed on 29th June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021289s019lbl.pdf
- Goodman & Gilmanâs, The Pharmacological Basis of Therapeutics, Introduction to endocrinology: The hypothalamic-pituitary axis, 12th edition, 2011, 1124.
- KD Tripathi, Essentials of Medical Pharmacology, Anterior pituitary hormones, 7th edition, 2013, 241.
Safety Advice
Pregnancy: unsafe Ovufol HP 75IU Injection is unsafe to administer in pregnant women because it may affect the fetus. Inform your physician if you are pregnant, suspect pregnancy, or planning to become pregnant.
Lungs: Consult your doctor It is unknown whether Ovufol HP 75IU Injection can be used in patients with liver disorders. Consult your doctor if you have any liver problems before starting the treatment.
Breastfeeding: unsafe Breastfeeding is not recommended in patients taking Ovufol HP 75IU Injection because the medicine passes into the breast milk in small amounts and may harm your baby.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.